Picture of Forward Pharma A/S logo

FWPAY — Forward Pharma A/S News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro Cap

Brief: Forward Pharma says U.S. patent office declares interference between Co and Biogen regarding treatment of multiple sclerosis

April 14 (Reuters) - Forward Pharma A/S  FWP.O : 
 * U.S. patent office declares an interference between Forward Pharma and Biogen 
   regarding the treatment of multiple sclerosis 
 
 * Source text for Eikon  ID:nGNXVDGLOa  
 
 * Further company coverage  FWP.O   
((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Forward Pharma A/S

See all news